Rx-Shooter Wearable Wound Infection Treatment Device

The Defense Health Agency seeks to develop a novel wearable wound infection treatment delivery device capable of delivering treatment for the prevention of infection in a prolonged care setting. Critical Innovations, KARA & Associates, and consultants Loren Miller, MD, MPH, Captain David Tanen, MD, FAAEM, FACMT (USN, Ret.), and former Commander Denise Whitfield, MD, FACET (USN), have formed a team of experts to address this important need. During Phase I, our objectives will be to further advance the innovative Rx-Shooter product. This will include: 1) On-boarding program requirements, goals, and schedule; 2) Developing a proof-of-concept Rx-Shooter prototype that addresses applicable treatment requirements; 3) Performing benchtop testing on the Rx-Shooter to demonstrate feasibility; 4) Maintaining and compiling all regulatory compliance requirements while preparing for upcoming regulatory hurdles.